seen from United States
seen from United States
seen from United States
seen from Germany
seen from Netherlands
seen from United States
seen from United States
seen from Germany
seen from United States
seen from Yemen
seen from United States
seen from Malaysia
seen from Germany
seen from United States
seen from Netherlands
seen from Malaysia
seen from China
seen from Colombia
seen from United States
seen from United States
WCR
Cherry Taffy
Cherry Slush
Shop Aora’s best-selling wellness solutions crafted with science-backed nutrition for complete health and long-term wellness.
Scientists Take Notice of Two Remarkable Probiotic Strains
In today's health-conscious world, the importance of maintaining a balanced gut microbiota can't be overstated. In the field of biotechnology, the pivotal role of probiotics in fortifying the digestive system and their astounding potential in promoting overall wellness. Particularly, two probiotic strains are catching the eyes of scientists: Bifidobacterium bifidum and Bifidobacterium longum.
Probiotic strains are simply live microorganisms, predominantly bacteria and yeasts, that confer a myriad of health benefits when administered in apt amounts. They inhabit various environments in your body, with a significant majority dwelling in the gut. These "friendly" microbes contribute to your health by aiding digestion, boosting immune defense, and warding off "unfriendly" bacteria that could cause diseases.
Bifidobacterium bifidum is one of the most common probiotic strains found in the human body, particularly in the intestines and vagina, where they fight off unfriendly bacteria, fungi, and yeast. Interestingly, this strain is among the first beneficial bacteria to colonize bodies at birth. Studies have shown that Bifidobacterium bifidum can curb the growth of harmful bacteria, enhance the body's immune system, and help in the digestion and absorption of dairy products. It may also alleviate Irritable Bowel Syndrome (IBS), alleviate constipation, and reduce the risk of obesity.
Bifidobacterium longum, on the other hand, is a powerhouse probiotic strain that has long been recognized for its integral role in maintaining a healthy gut. As one of the first bacteria to colonize bodies at birth, Bifidobacterium longum assists in breaking down carbohydrates, fighting harmful bacteria, and neutralizing everyday toxins found in the gut. Also, recent research suggests that this strain may play a part in alleviating symptoms of stress and anxiety.
Moreover, both Bifidobacterium bifidum and Bifidobacterium longum strains appear to have anti-inflammatory properties and may help balance the immune system to prevent allergic reactions. There is also evidence that these bifidobacteria strains may confer benefits to the skin by reducing the severity of certain dermatological conditions, such as atopic dermatitis and acne.
In conclusion, Bifidobacterium bifidum and Bifidobacterium longum represent the burgeoning field of probiotics research. These powerful probiotic strains not only enhance digestive health but also contribute to immune function, mental well-being, and potentially skin health. As the understanding of these beneficial microbes continues to grow, so does the appreciation for their profound impact on people's overall health and wellness.
Shedding Pounds with Science: Unveiling Probiotic Strains Designed for Weight Loss
This post delves into the science behind probiotic strains that are specifically tailored to assist in weight loss, and how they might be the missing puzzle piece in your wellness regimen. #nutribliss
In recent years, the quest for weight loss has shifted from mere calorie counting to a more nuanced understanding of the human body. Among the ground-breaking discoveries is the role that gut microbiota play in our overall health and weight management. Probiotic strains, in particular, have emerged as intriguing agents in the battle against the bulge, offering a novel approach to shedding…
Recent Emerging Gut Microbiome Management Modalities in Acute Diarrhea in Children: A comparative Study Review of Different Probiotic Strains: an Update by Amr I
Abstract
Aims & Objectives: Acute Diarrhea (AD) is a highly prevalent condition that causes significant morbidity and mortality worldwide. Conventional therapies include Oral Rehydration Solutions (ORS), Antibiotics and Zinc Products. Emerging data suggest that Probiotics use in the treatment & control of AD cases in children may help supplement current therapies for further control.
Methods: Herein, we review the evidence of several Probiotics modalities for AD treatment. We describe the Clinical Impact & prevalence of Acute Diarrhea in children and its complications, provide an overview of current treatments, and finally, discuss recent emergent Gut approaches to AD management. Specifically, we will describe - in a Comparative study - on the utility of different kinds of Probiotics known & used and common natural products in the treatment of Acute cases of AD and focus on recent, high-quality studies. Adverse effects and potential interactions of each therapy will be highlighted where applicable.
Keywords: Probiotic strains; Diarrhea; Intestinal colonization; GUT Microbiome; Dehydration; LrGG
Introduction
Acute Diarrheal Diseases considered as the most common leading causes of children mortality all over the globe. Today, only 39 per cent of children with Diarrhea in developing countries receive the recommended treatment, and limited trend data suggest that there has been little progress since 2000, more than 386000 children dies in India only due to A. Diarrhea every year. An international commitment to tackle childhood Diarrhea in the 1970s and 1980s resulted in a major reduction in child deaths. This came about largely through the scaling up of oral rehydration therapy, coupled with programs to educate caregivers on its appropriate use. But these efforts lost momentum as the world turned its attention to other global emergencies. Our review aims to search & updates the Evidence-Based Review Articles that study the use of specific probiotic strains, namely Lactobacillus Rhamnosus GG (LGG) and Saccharomyces boulardii, for the management of children with Acute Gastroenteritis (AGE) as an adjunct to rehydration therapy. This Literature Review also aim to show us the role of different probiotics in the treatment of acute diarrhea in children.
‘‘Probiotics May be an Effective adjunct to the Management of Diarrhea".
Rhamnosus GG (LGG) significantly reduced duration of diarrhea, daily stool outputs, improved stool consistency and reduced no. of hospitalization and fever in children compared to other probiotics (B. clausii and S. boulardii) & ORS group as we will discuss now. The guidelines recommend the use of the specific probiotic strains, namely Lactobacillus rhamnosus GG (LGG) and Saccharomyces boulardii, for the management of children with acute gastroenteritis (AGE) as an adjunct to rehydration therapy.
Discussion
The Efficacy of any probiotic is strain-dependent. Lactobacillus acidophilus strain is effective in IBS but not in AAD. Bifidobacterium bifidum reported that one strain (CIDCA5310) inhibited enterocyte invasion by Salmonella arizonae, whereas the other (CIDCA 537) had no effect. Lactobacillus rhamnosus GG (ATCC) help in treatment of Acute diarrhea, Persistent diarrhea, Rotavirus diarrhea, Gastroenteritis, AAD (Antibiotic Associated Diarrhea) Prevention & Treatment,Traveller’s diarrhea, Nosocomial diarrhea, Irritable Bowel Syndrome (IBS), Abdominal pain, Crying etc. , Ulcerative colitis, Necrotizing Enterocolitis (NEC) in pre-term infants, As an adjuvant to vaccines to stimulate immunity, Gastrointestinal infections & Respiratory Infections. L. Rhamnosus GG-Age group help in treatment of Acute infectious diarrhea, Antibiotic-Associated Diarrhea (AAD), Nosocomial diarrhea, Acute Gastroenteritis (AGE), Irritable Bowel Syndrome (IBS), Preventing infections, Allergic diseases, C. difficile diarrhea Pouchitis, Adjuvant therapy for H. pylori Eradication.
Proved Advantages & Clinical Benefits Of LGG Probiotic Strains Use
Lactobacillus rhamnosus GG (ATCC 53103) has a safe history of use in since1990
Can even be given to a 24 hrs old neonate
Clinically studied in various age group population starting from new born preterm infants to elderly population
Clinically studied at various dosage range starting (120mn CFU to 2000bn CFU/d)
Do probiotics work in Acute Infectious Diarrhea
63 trial, 8014 subjects
That Study Concluded That
Its use reduced the duration of diarrhea by around 25 hours
Risk of diarrhea be > 4 days by 59%
& One fewer diarrheal stool on day 2 after the intervention
That study concluded that : The use of LrGG P. Strains;
LrGG group has shown highest & significant efficacy in terms of reducing duration of diarrhea compared to other probiotics & ORS group.
Reduce In Daily Stool Outputs: LrGG group has shown significant reduction in terms of no. of stools per day on Day-2 compared to other probiotics & ORS group.
Improve In Stool Consistency: LrGG group has shown significant improvement in terms of stool consistency on
Day-2 compared to other probiotics & ORS group.
Recent Content Analysis Report Of Various Probiotic Brands(Indian Pediatrics, April 2018 Issue …)
Comparative Study of 3 Brands. Enterogermina vs. Tufpro vs. Darolac Aqua ;
That comparative review stated only product 1 was found to contain a homogenous population of bacillus clausii where as product 2 and product 3 showed growth of bacillus subiilis species in the samples.
Table 1: Probiotics for treatment of acute diarrhoea in children: Randomised clinical trial of five different Preparations
Comparative clinical study; L. rhamnosus GG vs, B. clausii vs. S. boulardii
Study design
This Study designed to compare the efficacy of 5 different preparations recommended to parents in the treatment of acute diarrhea in children.
Design: Prospective randomized controlled clinical trial.
Study Arm: N=571 children (age 3-36 months).
Duration: 5 days.
Conclusions
Our mini review aims to use of the specific probiotic strains, namely Lactobacillus Rhamnosus GG (LGG) and Saccharomyces boulardii, for the management of children with Acute Gastroenteritis (AGE) as an adjunct to rehydration therapy.2 The aim of this Mini Review also is to show us the role of probiotic in the treatment of acute diarrhea in children. We review the evidence of several Probiotics modalities for AD treatment. We describe the Clinical Impact & prevalence of Acute Diarrhea in children and its complications, provide an overview of current treatments, and finally, discuss recent emergent Gut approaches to AD management. Specifically, we will describe - in a Comparative study - on the utility of different kinds of Probiotics known & used and common natural products in the treatment of Acute cases of AD and focus on recent, high-quality studies. Adverse effects and potential interactions of each therapy will be highlighted where applicable. Some probiotics agents have a Beneficiary effects on the onset , course of acute Diarrheal illnesses but still in need for further reviews on the side effects & safety of such agents.
For more information about Article :
https://ijclinmedcasereports.com/ijcmcr-rw-id-00102/ https://ijclinmedcasereports.com/pdf/IJCMCR-RW-00102.pdf
Global Probiotic Strains Market 2020–2029 | Analysis by Forecast, Growth Opportunities, Major Key Players, Revenues During Covid-19 Outbreak
Global Probiotic Strains Market 2020–2029 | Analysis by Forecast, Growth Opportunities, Major Key Players, Revenues During Covid-19 Outbreak
KandJ market research added a new market research report on 2014-2029 Global Probiotic Strains Market by Player, Region, Type, Application and Sales Channel in the database of market research collaterals consisting of overall market scenario with prevalent and future growth prospects, among other growth strategies used by key players to stay ahead of the market.
Report Overview
It is our…
View On WordPress
